FRANKFURT/WASHINGTON (Reuters) – Bayer (BAYGn.DE) won U.S. antitrust approval for its planned takeover of Monsanto (MON.N) on condition that it sells about $9 billion in assets, the Justice Department said on Tuesday, clearing a major hurdle for the $62.5 billion deal.
The divestiture required by U.S. antitrust enforcers “aligns closely” with divestitures the European Union required, according to a source knowledgeable about the agreement between Bayer and the U.S. government. Continue reading “Bayer wins U.S. approval for Monsanto deal”
